This article was originally published in The Tan Sheet
Comments regarding FDA's draft guidance on the use of a column format for required "Drug Facts" information will be accepted through Jan. 31, the agency announces in the Dec. 1 Federal Register. The guidance, which clarifies that columns may be used by placing multiple "Drug Facts" boxes on each side of a label or package, appears on the agency's Web site (www.fda.gov/cder/guidance/index.htm) (1"The Tan Sheet" Nov. 29, p. 3)
You may also be interested in...
A two-column format for required information on OTC drug labels can be used by placing multiple "Drug Facts" boxes on each side of a product package, FDA states in a draft guidance posted on the agency's Web site the week of Nov. 22.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning